Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.
Savonitto S, Cavallini C, Petronio AS, Murena E, Antonicelli R, Sacco A, Steffenino G, Bonechi F, Mossuti E, Manari A, Tolaro S, Toso A, Daniotti A, Piscione F, Morici N, Cesana BM, Jori MC, De Servi S; Italian Elderly ACS Trial Investigators. Savonitto S, et al. Among authors: petronio as. JACC Cardiovasc Interv. 2012 Sep;5(9):906-16. doi: 10.1016/j.jcin.2012.06.008. JACC Cardiovasc Interv. 2012. PMID: 22995877 Free article. Clinical Trial.
Early aggressive vs. initially conservative treatment in elderly patients with non-ST-elevation acute coronary syndrome: the Italian Elderly ACS study.
Savonitto S, De Servi S, Petronio AS, Bolognese L, Cavallini C, Greco C, Indolfi C, Visconti LO, Piscione F, Ambrosio G, Galvani M, Marzocchi A, Santilli I, Steffenino G, Maseri A. Savonitto S, et al. Among authors: petronio as. J Cardiovasc Med (Hagerstown). 2008 Mar;9(3):217-26. doi: 10.2459/JCM.0b013e3282f7c8df. J Cardiovasc Med (Hagerstown). 2008. PMID: 18301136 Clinical Trial.
Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
Tamburino C, Di Salvo ME, Capodanno D, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S. Tamburino C, et al. Among authors: petronio as. Am J Cardiol. 2009 Jan 15;103(2):187-93. doi: 10.1016/j.amjcard.2008.08.059. Epub 2008 Oct 30. Am J Cardiol. 2009. PMID: 19121434
Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry.
Capodanno D, Di Salvo ME, Palmerini T, Sheiban I, Margheri M, Vecchi G, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Filippone V, De Servi S, Tamburino C. Capodanno D, et al. Among authors: petronio as. Catheter Cardiovasc Interv. 2009 Feb 15;73(3):310-6. doi: 10.1002/ccd.21845. Catheter Cardiovasc Interv. 2009. PMID: 19214964
[The FINESSE trial].
Petronio AS, Piscione F. Petronio AS, et al. G Ital Cardiol (Rome). 2009 Jan;10(1):1-5. G Ital Cardiol (Rome). 2009. PMID: 19292014 Italian. No abstract available.
Impact of drug-eluting stents and diabetes mellitus in patients with coronary bifurcation lesions: a survey from the Italian Society of Invasive Cardiology.
Capodanno D, Tamburino C, Sangiorgi GM, Romagnoli E, Colombo A, Burzotta F, Gasparini GL, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Ettori F, Franco G, Di Girolamo D, Sheiban I, Piatti L, Greco C, Petronio AS, Loi B, Lyoi E, Benassi A, Patti A, Gaspardone A, De Servi S; I-BIGIS Study Group. Capodanno D, et al. Among authors: petronio as. Circ Cardiovasc Interv. 2011 Feb 1;4(1):72-9. doi: 10.1161/CIRCINTERVENTIONS.110.959460. Epub 2011 Jan 4. Circ Cardiovasc Interv. 2011. PMID: 21205940
Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score.
Biondi-Zoccai G, Romagnoli E, Castagno D, Sheiban I, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Niccoli L, Franco G, Di Girolamo D, Piatti L, Greco C, Petronio AS, Loi B, Benassi A, Patti A, Gaspardone A, Frati G, Sangiorgi G. Biondi-Zoccai G, et al. Among authors: petronio as. EuroIntervention. 2012 Jul 20;8(3):359-67. doi: 10.4244/EIJV8I3A55. EuroIntervention. 2012. PMID: 22584142 Free article.
Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: the INtegrilin plus STenting to Avoid myocardial Necrosis Trial.
Biondi-Zoccai G, Valgimigli M, Margheri M, Marzocchi A, Lettieri C, Stabile A, Petronio AS, Binetti G, Bolognese L, Bellone P, Sardella G, Contarini M, Sheiban I, Marra S, Piscione F, Romeo F, Colombo A, Sangiorgi G. Biondi-Zoccai G, et al. Among authors: petronio as. Am Heart J. 2012 May;163(5):835.e1-7. doi: 10.1016/j.ahj.2012.02.009. Am Heart J. 2012. PMID: 22607870 Clinical Trial.
360 results